Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine vs Risperidone on Quality of Life in Female Schizophrenia
NCT00498004Phase 4Terminated
- Sponsor
- Inje University
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of quetiapine in schizophrenia (2 arms), sponsored by Inje University. Primary endpoint: Heinrich's Quality of Life Scale at 8 weeks. Started Aug 2007; status: terminated.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00498004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498004.